【讲座论坛】斯坦福大学Bruce Ling博士谈大数据在医疗保健管理和智慧医疗中的应用

已结束

时间： 1970-01-01 08:33

地点：紫金港校区行政楼1102会议室

讲座嘉宾：Bruce Ling 博士

                斯坦福大学转化医学中心主任研究员

                HBI Solutions Inc.联合创始人；Principal Investigator，Stanford                           Transformational Medicine Center， Co-founder， HBI Solutions Inc

讲座时间：2013年10月17日上午10：00-11:30

讲座地点：管理学院1102会议室

主持人：  郑刚 副教授

注：本次活动非商务实践活动

 

Bruce Ling 博士简历：

Dr. Bruce Ling is a Principal Investigator at Stanford University School of Medicine and has built a multi-facted laboratory of translational medicine. His wet lab utilizes muliti-omics based, high throughput, and high content approaches to identify diagnostic and prognostic utilities for personalized and point of care medicine. His computational lab currently focuses on novel statistical learning algorithm innovation, large scale scientific computing and robust experimental design. Prior to that, he was a Research Director at Tularik Inc responsible for large scale genomics target identification and high throughput screening of lead compounds. Later Tularik was acquired by Amgen for $1.3 billion and gave Amgen access to a trove of potential medications for cancer and inflammatory diseases. Within his tenure at Stanford University, Dr. Ling co-foundered HBI Solutions in 2011 and focuses on health care analytic solution development, including predictive modeling, and co-founded Carmenta Bioscience in 2012 to develop diagnostic tools to manage the disease of preeclampsia in pregnant women.